Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice

Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice

Diana Canetti,1 Laura Galli,1 Riccardo Lolatto,1 Silvia Nozza,2 Vincenzo Spagnuolo,1 Camilla Muccini,1 Benedetta Trentacapilli,2 Elena Bruzzesi,2 Martina Ranzenigo,2 Matteo Chiurlo,2 Antonella Castagna,1,2 Nicola Gianotti1 1Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, Italy; 2...

Full description

Bibliographic Details
Main Authors: Canetti D, Galli L, Lolatto R, Nozza S, Spagnuolo V, Muccini C, Trentacapilli B, Bruzzesi E, Ranzenigo M, Chiurlo M, Castagna A, Gianotti N
Format: Article
Language:English
Published: Dove Medical Press 2023-12-01
Series:Drug Design, Development and Therapy
Subjects:
bictegravir
people living with hiv
plwh
efficacy
safety
clinical practice.
Online Access:https://www.dovepress.com/bictegraviremtricitabinetenofovir-alafenamide-treatment-efficacy-and-t-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/bictegraviremtricitabinetenofovir-alafenamide-treatment-efficacy-and-t-peer-reviewed-fulltext-article-DDDT

Similar Items